California’s Applied Molecular Transport has become the latest biotech to go for an IPO during the pandemic, aiming to raise $100 million to take an oral ulcerative colitis drug into phase 2 ...
After 45 years of service, including eight years as Caterpillar’s CEO, D. James Umpleby III will retire as Executive Chairman. The Caterpillar brand represents the whole corporation and our people.